• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Financial Distress Driving Q3 Healthcare Deals

Share:

October 17, 2023

In Q3 2023, over one-third of hospital and health system transactions were driven by financial distress, according to Kaufman Hall’s M&A report. Despite one major merger, the quarter saw 18 transactions totaling $8.2 billion in revenue, signaling renewed momentum as healthcare entities seek sustainable alliances. Notably, not-for-profit systems led 14 of these transactions, including seven academic/university-affiliated organizations, while for-profit systems acquired financially distressed smaller entities in the remaining four cases. Seller size and total revenue remained historically high.

More than one-third of hospital and health system transactions announced in Q3 2023 involved a party that cited financial distress as a transaction driver, according to Kaufman Hall’s latest mergers and acquisitions (M&A) report. The reports reveal third quarter M&A activity remained high with 18 announced transactions resulting in $8.2B in total transacted revenue.

– Kaufman Hall experts say transaction activity is regaining momentum as hospitals, health systems, and other healthcare organizations seek new alliances, partnerships, and ultimately, long-term financial sustainability.

– Despite only one “mega-merger” transaction—in which the smaller party has annual revenues above $1 billion—Q3 average seller size and total transacted revenue remain above historical levels.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Other key findings from the report include:

– Not-for-profit health systems were the acquiring or larger party in 14 of Q3’s 18 announced transactions, with for-profit systems acting as the acquiring party in the remaining four transactions.

– Of the 14 not-for-profit acquirers, seven were academic/university-affiliated organizations (see discussion below) and one was a religiously affiliated organization.

– The four transactions in which a for-profit system acted as acquirer focused primarily on smaller, financially distressed organizations: three of the four acquired organizations were financially distressed.

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Ionis Pharmaceuticals to Acquire Remaining stake in Akcea TherapeuticsIonis Pharmaceuticals to Acquire Remaining stake in Akcea Therapeutics
  • Towa Pharmaceutical Co., Ltd. Reaches An Agreement with Esteve to Acquire Esteve’s Generic Division, Pensa InvestmentsTowa Pharmaceutical Co., Ltd. Reaches An Agreement with Esteve to Acquire Esteve’s Generic Division, Pensa Investments
  • Muconic Acid Market Expansion to Be Persistent During 2020-2029 | Myriant, Amyris, Santa Cruz BiotechnologyMuconic Acid Market Expansion to Be Persistent During 2020-2029 | Myriant, Amyris, Santa Cruz Biotechnology
  • Wellin5 Acquires Mental Health Journaling and Tracking App TherachatWellin5 Acquires Mental Health Journaling and Tracking App Therachat
  • GTCR Announces Partnership with Healthcare Leader Gregory T. Lucier to Form Corza HealthGTCR Announces Partnership with Healthcare Leader Gregory T. Lucier to Form Corza Health
  • Australia’s Prospection Raises A$10M in Series a FundingAustralia’s Prospection Raises A$10M in Series a Funding
  • Blue Cross Becomes First Health Plan to Offer Direct Integration with PillPackBlue Cross Becomes First Health Plan to Offer Direct Integration with PillPack
  • Enzolytics, Inc. Reports Amendment to Non-Binding Term Sheet with the Special Purpose Acquisition Company Sagaliam Acquisition Corp.Enzolytics, Inc. Reports Amendment to Non-Binding Term Sheet with the Special Purpose Acquisition Company Sagaliam Acquisition Corp.

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications